Adhesion Barrier Market by Type (Synthetic Adhesion Barriers and Natural Adhesion Barriers), Formulation (Film Formulations, Gel Formulations, and Liquid Formulations), Application (Abdominal Surgeries, Gynecological Surgeries, Neurological Surgeries, Orthopedic Surgeries, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026781 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 790.23 million mark in 2022 and is expected to hit US$ 1,493.72 million by 2030, recording a CAGR of 7.20% during the forecast period.   

Adhesion barriers market is growing due to high incidence rate of post-operative adhesion.

Approximately 9 million pelvic and abdominal surgeries are performed every year in the United States. Abdominal adhesion is one of the most common complications which is observed after surgery. About 90-93% of patients who undergo abdominal surgeries suffer from post-operative adhesion. Out of these abdominal adhesion about 60% of patients suffer from small bowel obstruction and develop chronic pelvic pain. The adhesion rate in gynaecological surgeries ranges from 73%-90% which may lead to chronic pain, infertility, or bowel obstruction. This is driving the demand for adhesion barrier to prevent these post-operative adhesion and other complications related to it. The abdominal surgery segment is expected to grow at a higher rate due to the increase in number of abdominal surgeries and the number of complications related to abdominal adhesions.

Within the report, the market is segmented into type, delivery mode, application, end user, and geography. On the basis of type, the market is bifurcated into synthetic adhesion barrier and natural adhesion barrier. By synthetic adhesion barrier, the type segment is further divided into hyaluronic acid, regenerated cellulose, polyethylene glycol, and others. By natural adhesion barrier, the type segment is further bifurcated into collagen protein and fibrin. Based on formulation, the market is divided into film formulations, gel formulations, and liquid formulations. On the basis of application, the market is categorized into abdominal surgeries, gynecological surgeries, neurological surgeries, and orthopedic surgeries. Based on end user, the market is divided hospitals, ambulatory surgical centers, and specialty clinics. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Awareness of benefits of adhesion barriers in emerging economies empowered the futuristic growth.

Adhesions are bands of scar-like tissue that form between two surfaces inside the body and cause them to stick. Generally, internal organs and tissues have slippery surfaces therefore they can shift easily as the body moves. Due to adhesion, these organs and tissues may stick together causing complications, such as chronic pain, infertility, bloating, vomiting, etc. in the body. In emerging economies, such as India, China, South Korea, Mexico, Brazil, etc., the awareness and penetration of adhesion barriers is very low as compared to developed economies. The growing medical tourism for various surgeries due to low cost in emerging economies, the increase in overall number of surgeries, and presence of large patient pool in this region is expected to create opportunity for demand of adhesion barriers.

Establishment of technologically advanced hospitals in emerging economies is one of the major factors accelerating the market growth.

The end user for adhesion barriers are hospitals, ambulatory surgical centers, and specialty clinics. Within these end users, hospitals are one such end user, wherein the use of adhesion barriers is increasing due to the increase in number of surgeries carried out in hospitals. There is increase in establishment of hospitals in developing regions and in developed regions hospitals are focusing on upgrading their infrastructure and technology.  Increase in number of abdominal and gynecological surgeries carried out in hospitals is also propelling the growth of the segment.

Recent strategic developments in adhesion barriers market

The adhesion barriers market has undergone several significant developments, and a few of these have been mentioned below:

  • In February 2022, Gunze Ltd., headquartered in Osaka, Japan, announced that it has obtained medical device approval to manufacture and sell TENALEAF absorbable adhesion barrier in Japan.
  • In February 2020, Baxter International Inc. announced that it has completed acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million. The Seprafilm product family, which is used as an adjunct to reduce the incidence, extent, and severity of adhesions in certain pelvic and abdominal surgeries, currently has a global commercial presence in the U.S., Japan, China, South Korea and France, among other countries.
  • In October 2018, FzioMed Inc. announced that it has launched Oxiplex/IU adhesion barrier gel which can be used in intrauterine surgeries. It is an absorbable, synthetic viscoelastic gel that is applied following intrauterine surgery to preserve uterine integrity and improve surgical outcomes by reducing post-surgical adhesions.

The adhesion barrier market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. FzioMed Inc., Baxter International Inc., Betatech Medical, Ginze Ltd., Johnson and Johnson, Integra Lifesciences, Anika Therapeutics, Atrium Medical Corporation, MAST Biosurgery, and Innocoll are among the prominent players operating in the market.

Target audience for the report:

  • Raw material providers
  • Healthcare related service providers
  • Healthcare-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Type:
    • Synthetic Adhesion Barrier
      • Hyaluronic Acid
      • Regenerated Cellulose
      • Polyethylene Glycol
      • Others
    • Natural Adhesion Barrier
      • Collagen & Protein
      • Fibrin
  • Formulation
    • Gel Formulation
    • Film Formulation
    • Liquid Formulation
  • Application:
    • Abdominal Surgeries
    • Gynecological Surgeries
    • Neurological Surgeries
    • Orthopedic Surgeries
  • End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • FzioMed Inc.
    • Baxter International Inc.
    • Betatech Medical
    • Ginze Ltd.
    • Johnson and Johnson
    • Integra Lifesciences
    • Anika Therapeutics
    • Atrium Medical Corporation
    • MAST Biosurgery
    • Innocoll

The List of Companies
- FzioMed Inc.
- Baxter International Inc.
- Betatech Medical
- Ginze Ltd.
- Johnson and Johnson
- Integra Lifesciences
- Anika Therapeutics
- Atrium Medical Corporation
- MAST Biosurgery
- Innocoll

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000